These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 18412394

  • 1. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N, Heard C.
    J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
    [Abstract] [Full Text] [Related]

  • 2. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's Claw).
    Ouitas NA, Heard C.
    Phytother Res; 2010 Mar; 24(3):333-8. PubMed ID: 19610038
    [Abstract] [Full Text] [Related]

  • 3. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N, Tramonti G, Corti A, Chieli E.
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [Abstract] [Full Text] [Related]

  • 4. A new iridoid diglucoside from Harpagophytum procumbens.
    Tomassini L, Serafini M, Foddai S, Ventrone A, Nicoletti M.
    Nat Prod Res; 2016 Dec; 30(2):157-61. PubMed ID: 26119468
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
    Kaszkin M, Beck KF, Koch E, Erdelmeier C, Kusch S, Pfeilschifter J, Loew D.
    Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
    [Abstract] [Full Text] [Related]

  • 6. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
    Anauate MC, Torres LM, de Mello SB.
    Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
    [Abstract] [Full Text] [Related]

  • 7. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
    Qi J, Chen JJ, Cheng ZH, Zhou JH, Yu BY, Qiu SX.
    Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
    [Abstract] [Full Text] [Related]

  • 8. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N, Turner MW, McDougal OM.
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [Abstract] [Full Text] [Related]

  • 9. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations.
    Modarai M, Suter A, Kortenkamp A, Heinrich M.
    J Pharm Pharmacol; 2011 Mar; 63(3):429-38. PubMed ID: 21749392
    [Abstract] [Full Text] [Related]

  • 10. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N.
    J Ethnopharmacol; 2012 Oct 11; 143(3):755-71. PubMed ID: 22940241
    [Abstract] [Full Text] [Related]

  • 11. Itosides J-N from Itoa orientalis and structure - anti-COX-2 activity relationship of phenolic glycosides.
    Chai XY, Song YL, Xu ZR, Shi HM, Bai CC, Bi D, Wen J, Li FF, Tu PF.
    J Nat Prod; 2008 May 11; 71(5):814-9. PubMed ID: 18412396
    [Abstract] [Full Text] [Related]

  • 12. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
    Mncwangi NP, Viljoen AM, Zhao J, Vermaak I, Chen W, Khan I.
    Phytochemistry; 2014 Oct 11; 106():104-115. PubMed ID: 25041697
    [Abstract] [Full Text] [Related]

  • 13. Harpagoside: from Kalahari Desert to pharmacy shelf.
    Georgiev MI, Ivanovska N, Alipieva K, Dimitrova P, Verpoorte R.
    Phytochemistry; 2013 Aug 11; 92():8-15. PubMed ID: 23642455
    [Abstract] [Full Text] [Related]

  • 14. The Fight against Infection and Pain: Devil's Claw (Harpagophytum procumbens) a Rich Source of Anti-Inflammatory Activity: 2011-2022.
    Gxaba N, Manganyi MC.
    Molecules; 2022 Jun 06; 27(11):. PubMed ID: 35684573
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
    Inaba K, Murata K, Naruto S, Matsuda H.
    J Nat Med; 2010 Apr 06; 64(2):219-22. PubMed ID: 20177800
    [Abstract] [Full Text] [Related]

  • 16. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.
    Ouitas NA, Heard CM.
    Int J Pharm; 2009 Jul 06; 376(1-2):63-8. PubMed ID: 19383533
    [Abstract] [Full Text] [Related]

  • 17. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro.
    Abdelouahab N, Heard CM.
    Planta Med; 2008 Apr 06; 74(5):527-31. PubMed ID: 18401847
    [Abstract] [Full Text] [Related]

  • 18. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
    Hostanska K, Melzer J, Rostock M, Suter A, Saller R.
    J Pharm Pharmacol; 2014 Nov 06; 66(11):1606-14. PubMed ID: 25175765
    [Abstract] [Full Text] [Related]

  • 19. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
    Joubert E, Manley M, Gray BR, Schulz H.
    J Agric Food Chem; 2005 May 04; 53(9):3493-502. PubMed ID: 15853393
    [Abstract] [Full Text] [Related]

  • 20. Formation of nitrogen-containing metabolites from the main iridoids of Harpagophytum procumbens and H. zeyheri by human intestinal bacteria.
    Baghdikian B, Guiraud-Dauriac H, Ollivier E, N'Guyen A, Dumenil G, Balansard G.
    Planta Med; 1999 Mar 04; 65(2):164-6. PubMed ID: 10193209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.